These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11996813)

  • 41. Evaluation of Cetylpyridinium Chloride-Containing Mouthwashes Using In Vitro Disk Retention and Ex Vivo Plaque Glycolysis Methods.
    Hunter-Rinderle SJ; Bacca LA; McLaughlin KT; Macksood D; Lanzalaco AC; Parran J; Doyle MJ
    J Clin Dent; 1997; 8(4):107-13. PubMed ID: 26630720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted retentive device for oro-dental infections: formulation and development.
    Ahuja A; Ali J; Sarkar R; Shareef A; Khar RK
    Int J Pharm; 2003 Jun; 259(1-2):47-55. PubMed ID: 12787635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A 6-month clinical trial to study the effects of a cetylpyridinium chloride mouthrinse on gingivitis and plaque.
    Mankodi S; Bauroth K; Witt JJ; Bsoul S; He T; Gibb R; Dunavent J; Hamilton A
    Am J Dent; 2005 Jul; 18 Spec No():9A-14A. PubMed ID: 16178130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of hydroxypropyl methylcellulose matrix systems as swellable gastro-retentive drug delivery systems (GRDDS).
    Matharu AS; Motto MG; Patel MR; Simonelli AP; Dave RH
    J Pharm Sci; 2011 Jan; 100(1):150-63. PubMed ID: 20572054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A clinical study to assess the 12-hour antimicrobial effects of cetylpyridinium chloride mouthwashes on supragingival plaque bacteria.
    He S; Wei Y; Fan X; Hu D; Sreenivasan PK
    J Clin Dent; 2011; 22(6):195-9. PubMed ID: 22403975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Superiority of an essential oil mouthrinse when compared with a 0.05% cetylpyridinium chloride containing mouthrinse: a six-month study.
    Sharma NC; Araujo MW; Wu MM; Qaqish J; Charles CH
    Int Dent J; 2010 Jun; 60(3):175-80. PubMed ID: 20684443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vitamin B12 buccoadhesive tablets: auspicious non-invasive substitute for intra muscular injection: formulation, in vitro and in vivo appraisal.
    Mohamad SA; Abdelkader H; Elrehany M; Mansour HF
    Drug Dev Ind Pharm; 2019 Feb; 45(2):244-251. PubMed ID: 30289003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Badam gum: a natural polymer in mucoadhesive drug delivery. Design, optimization, and biopharmaceutical evaluation of badam gum-based metoprolol succinate buccoadhesive tablets.
    Mylangam CK; Beeravelli S; Medikonda J; Pidaparthi JS; Kolapalli VR
    Drug Deliv; 2016; 23(1):195-206. PubMed ID: 24825493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride to control established dental plaque and gingivitis.
    Silva MF; dos Santos NB; Stewart B; DeVizio W; Proskin HM
    J Clin Dent; 2009; 20(2):55-61. PubMed ID: 19591338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiplaque/antigingivitis efficacy and safety of a cetylpyridinium chloride/zinc gluconate mucoadhesive gel. Results of a 6-month clinical trial.
    Lee SS; Aprecio RM; Zhang W; Arambula M; Wilkins KB; Stephens JA; Kim JS; Li Y
    Compend Contin Educ Dent; 2008 Jun; 29(5):302-4, 306, 308 passim. PubMed ID: 18795647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro and in vivo studies on HPMC-K-100 M matrices containing naproxen sodium.
    Kumar SM; Chandrasekar MJ; Gopinath R; Srinivasan R; Nanjan MJ; Suresh B
    Drug Deliv; 2007 Mar; 14(3):163-9. PubMed ID: 17454036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cetylpyridinium chloride mouth rinses alleviate experimental gingivitis by inhibiting dental plaque maturation.
    Teng F; He T; Huang S; Bo CP; Li Z; Chang JL; Liu JQ; Charbonneau D; Xu J; Li R; Ling JQ
    Int J Oral Sci; 2016 Sep; 8(3):182-90. PubMed ID: 27680288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Matrices containing NaCMC and HPMC 1. Dissolution performance characterization.
    Conti S; Maggi L; Segale L; Ochoa Machiste E; Conte U; Grenier P; Vergnault G
    Int J Pharm; 2007 Mar; 333(1-2):136-42. PubMed ID: 17207943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of brief cetylpyridinium chloride treatments during early and mature cariogenic biofilm formation.
    Pandit S; Cai JN; Jung JE; Lee YS; Jeon JG
    Oral Dis; 2015 Jul; 21(5):565-71. PubMed ID: 25600577
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the effects of cetylpyridinium chloride with an essential oil mouth rinse on dental plaque and gingivitis - a six-month randomized controlled clinical trial.
    Albert-Kiszely A; Pjetursson BE; Salvi GE; Witt J; Hamilton A; Persson GR; Lang NP
    J Clin Periodontol; 2007 Aug; 34(8):658-67. PubMed ID: 17635245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative bioavailability and antimicrobial activity of cetylpyridinium chloride mouthrinses in vitro and in vivo.
    Garcia-Godoy F; Klukowska MA; Zhang YH; Anastasia K; Cheng R; Gabbard M; Coggan J; White DJ
    Am J Dent; 2014 Aug; 27(4):185-90. PubMed ID: 25831600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An approach to efficacy screening of mouthrinses: studies on a group of French products (II). Inhibition of salivary bacteria and plaque in vivo.
    Harper PR; Milsom S; Wade W; Addy M; Moran J; Newcombe RG
    J Clin Periodontol; 1995 Sep; 22(9):723-7. PubMed ID: 7593704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of subinhibitory concentrations of chemical agents on hydrophobicity and in vitro adherence of Streptococcus mutans and Streptococcus sanguis.
    Cai S; Simionato MR; Mayer MP; Novo NF; Zelante F
    Caries Res; 1994; 28(5):335-41. PubMed ID: 8001055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitory effects of antiseptic mouthrinses on Streptococcus mutans, Streptococcus sanguinis and Lactobacillus acidophilus.
    Evans A; Leishman SJ; Walsh LJ; Seow WK
    Aust Dent J; 2015 Jun; 60(2):247-54; quiz 270. PubMed ID: 25989101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro oral biofilm formation on triclosan-coated sutures in the absence and presence of additional antiplaque treatment.
    Venema S; Abbas F; van de Belt-Gritter B; van der Mei HC; Busscher HJ; van Hoogmoed CG
    J Oral Maxillofac Surg; 2011 Apr; 69(4):980-5. PubMed ID: 20674122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.